Insights into the structure of hepatocyte growth factor/scatter factor (HGF/SF) and implications for receptor activation. 1998

D Y Chirgadze, and J Hepple, and R A Byrd, and R Sowdhamini, and T L Blundell, and E Gherardi
Department of Biochemistry, University of Cambridge, UK.

The modular structure of HGF/SF offers a reductionist or 'divide and rule' approach to the analysis of structure and function. Domain deletion experiments have established that the N domain, kringle 1 and kringle 2 are essential for HGF/SF activity and that truncated variants containing the N domain and kringle 1 (NK1) or kringles 1 and 2 (NK2) can exhibit partial agonistic or antagonistic activity depending on target cells. Comparative modelling has been used to predict the 3D structures of the six domains of HGF/SF. More recently, NMR methods have shown that the N domain has a novel fold, the charge distribution of which suggests a heparin binding site. Crystals of NK1 indicate the relationship of this domain to the kringle 1, offering further insights into the mechanism of domain interactions and receptor activation.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D016297 Mutagenesis, Site-Directed Genetically engineered MUTAGENESIS at a specific site in the DNA molecule that introduces a base substitution, or an insertion or deletion. Mutagenesis, Oligonucleotide-Directed,Mutagenesis, Site-Specific,Oligonucleotide-Directed Mutagenesis,Site-Directed Mutagenesis,Site-Specific Mutagenesis,Mutageneses, Oligonucleotide-Directed,Mutageneses, Site-Directed,Mutageneses, Site-Specific,Mutagenesis, Oligonucleotide Directed,Mutagenesis, Site Directed,Mutagenesis, Site Specific,Oligonucleotide Directed Mutagenesis,Oligonucleotide-Directed Mutageneses,Site Directed Mutagenesis,Site Specific Mutagenesis,Site-Directed Mutageneses,Site-Specific Mutageneses
D017228 Hepatocyte Growth Factor Multifunctional growth factor which regulates both cell growth and cell motility. It exerts a strong mitogenic effect on hepatocytes and primary epithelial cells. Its receptor is PROTO-ONCOGENE PROTEINS C-MET. Hepatopoietin,Hepatopoietin A,Scatter Factor,Factor, Hepatocyte Growth,Factor, Scatter,Growth Factor, Hepatocyte
D019859 Proto-Oncogene Proteins c-met Cell surface protein-tyrosine kinase receptors for HEPATOCYTE GROWTH FACTOR. They consist of an extracellular alpha chain which is disulfide-linked to the transmembrane beta chain. The cytoplasmic portion contains the catalytic domain and sites critical for the regulation of kinase activity. Mutations in the c-met proto-oncogene are associated with papillary renal carcinoma and other neoplasia. HGF Receptor,Hepatocyte Growth Factor Receptor,c-met Proteins,met Proto-Oncogene Proteins,MET Proto-Oncogene, Receptor Tyrosine Kinase,MET Receptor Tyrosine Kinase,Receptor, HGF,Receptor, Hepatocyte Growth Factor,Receptor, Scatter Factor,Scatter Factor Receptor,c-Met Receptor Tyrosine Kinase,MET Proto Oncogene, Receptor Tyrosine Kinase,Proto Oncogene Proteins c met,Proto-Oncogene Proteins, met,c Met Receptor Tyrosine Kinase,c met Proteins,met Proto Oncogene Proteins

Related Publications

D Y Chirgadze, and J Hepple, and R A Byrd, and R Sowdhamini, and T L Blundell, and E Gherardi
January 1993, EXS,
D Y Chirgadze, and J Hepple, and R A Byrd, and R Sowdhamini, and T L Blundell, and E Gherardi
January 1993, Symposia of the Society for Experimental Biology,
D Y Chirgadze, and J Hepple, and R A Byrd, and R Sowdhamini, and T L Blundell, and E Gherardi
January 1999, International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience,
D Y Chirgadze, and J Hepple, and R A Byrd, and R Sowdhamini, and T L Blundell, and E Gherardi
November 2003, Molecular cancer therapeutics,
D Y Chirgadze, and J Hepple, and R A Byrd, and R Sowdhamini, and T L Blundell, and E Gherardi
September 2004, Cancer letters,
D Y Chirgadze, and J Hepple, and R A Byrd, and R Sowdhamini, and T L Blundell, and E Gherardi
January 1994, Verhandlungen der Deutschen Gesellschaft fur Pathologie,
D Y Chirgadze, and J Hepple, and R A Byrd, and R Sowdhamini, and T L Blundell, and E Gherardi
September 2000, The Biochemical journal,
D Y Chirgadze, and J Hepple, and R A Byrd, and R Sowdhamini, and T L Blundell, and E Gherardi
April 1998, The American journal of pathology,
D Y Chirgadze, and J Hepple, and R A Byrd, and R Sowdhamini, and T L Blundell, and E Gherardi
August 1998, Leukemia,
D Y Chirgadze, and J Hepple, and R A Byrd, and R Sowdhamini, and T L Blundell, and E Gherardi
February 1994, Zeitschrift fur Gastroenterologie,
Copied contents to your clipboard!